Rubella Virus IgM Hybrid Human Monoclonal Antibody (BM1361)

Dublin, Ireland

Biosynth is a worldwide leader in high-quality in-vitro diagnostic reagents, offering an exceptional selection of research tools, specialized products for various research areas, and customized services designed for scientists and manufacturers in in-vitro diagnostics and research labs. Biosynth has carefully assembled a comprehensive offering, including: • Largest Provider of Bulk Disease State Plasma in Europe • Custom Antigen Manufacturing (ISO 13485:2016) • Routine Bulk Antigen and Antibody Production • Full Chemiluminescence Raw Material Menu • Extensive Range for Emerging Diseases: A curated selection of first-to-market proteins and monoclonal antibodies for viruses like Monkeypox, Zika, Chikungunya, Dengue, and SARS-CoV-2. • Support for Key Research Areas: A vast array of products for cancer, infectious disease, tropical viruses, neuroscience, endocrinology, immunology, and veterinary science.